Loading institutional data...
Loading institutional data...
Held by 165 of 5,944 reporting institutions (90th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $83.62 today, the market must believe free cash flow compounds 26.2%/yr for a decade (off $12M normalized FCF).
2-stage DCF · 0.01B shares · net debt $6M
mean -44.2% · volatility σ 75% · implied rate exceeded in 1/6 yrs
Central path = implied 26.2%/yr growth; shaded band = ±1σ (75%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $29.49T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $371.6B | 42.5× | 29.7× | 5.5× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.8B | 38.5× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $259.8B | 39.0× | 18.5× | 2.9× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $199.4B | 79.4× | 40.2× | 2.2× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $185.4B | 37.1× | — | 4.1× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $177.4B | 47.9× | 31.6× | 5.5× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $167.6B | 23.6× | 16.1× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $158.8B | 39.2× | — | 5.8× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.2B | 28.1× | 16.1× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.2B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $118.7B | 34.1× | 26.8× | 6.0× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.3B | 24.9× | — | 4.9× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $96.2B | 23.0× | 16.9× | 1.8× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.4B | 32.6× | 23.3× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| VRT | $92.4B | 70.8× | 43.8× | 9.0× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| PWR | $92.2B | 90.7× | 45.8× | 3.2× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| JCI | $91.9B | 28.0× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $90.7B | 60.9× | 39.9× | 11.0× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $87.3B | 27.4× | 16.8× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.0B | 31.8× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $85.0B | 15.3× | 9.5× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $83.0B | 36.5× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $79.8B | 45.0× | 28.7× | 7.7× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| GHM | $926M | 74.7× | 45.8× | 3.8× | 16.9% | 23.5% | 5.1% | 8.9% | 8.2% | 0.6× | 165 |
Peers = companies sharing GHM's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$121000 FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 8%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $7M covers the $2M due within a year 3.3× over. Scheduled principal only (excludes interest & revolver draws). As of 2023-03-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~2.0% on $13M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
Where each multiple sits in its own 15-yr range · 98th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 15-yr history.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 76.1 | 80.0 | 79.0 | 92.6 | 83.8 | 78.1 | 74.8 | 76.5 |
| Gross Profit | 23.9 | 20.0 | 21.0 | 7.4 | 16.2 | 21.9 | 25.2 | 23.5 |
| R&D | 3.9 | 3.7 | 3.5 | 3.1 | 2.6 | 2.1 | 1.9 | 2.6 |
| SG&A | 19.5 | 18.6 | 17.9 | 16.6 | 14.7 | 17.4 | 17.7 | 16.9 |
| Operating Income | — | 0.7 | 3.1 | -9.2 | 0.8 | 3.7 | 7.2 | 6.1 |
| Income Tax | 0.2 | 0.5 | 0.9 | -2.0 | 0.1 | 0.5 | 1.5 | 0.9 |
| Net Income | -0.3 | 2.1 | 2.4 | -7.1 | 0.2 | 2.5 | 5.8 | 5.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on GHM: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $245.3M 100.0% | $209.9M 100.0% | $185.5M 100.0% | $157.1M 100.0% | $122.8M 100.0% | $97.5M 100.0% | $90.6M 100.0% | $91.8M 100.0% | $77.5M 100.0% | $91.8M 100.0% |
| Cost of Revenue | $187.5M 76.5% | $157.0M 74.8% | $144.9M 78.1% | $131.7M 83.8% | $113.7M 92.6% | $77.0M 79.0% | $72.5M 80.0% | $69.9M 76.1% | $60.6M 78.1% | $69.6M 75.9% |
| Cost of Products | — | — | — | — | — | — | — | — | $60.2M 77.6% | $69.6M 75.9% |
| Gross Profit | $57.8M 23.5% | $52.9M 25.2% | $40.6M 21.9% | $25.4M 16.2% | $9.1M 7.4% | $20.5M 21.0% | $18.1M 20.0% | $21.9M 23.9% | $17.0M 21.9% | $22.2M 24.1% |
| Research & Development | $6.4M 2.6% | $4.0M 1.9% | $3.9M 2.1% | $4.1M 2.6% | $3.8M 3.1% | $3.4M 3.5% | $3.4M 3.7% | $3.5M 3.9% | $3.2M 4.1% | $3.9M 4.2% |
| Selling, General & Admin | $41.6M 16.9% | $37.1M 17.7% | $32.2M 17.4% | $23.1M 14.7% | $20.4M 16.6% | $17.5M 17.9% | $16.9M 18.6% | $17.9M 19.5% | $15.5M 20.0% | $14.6M 15.9% |
| Operating Income | $15.0M 6.1% | $15.2M 7.2% | $6.9M 3.7% | $1.3M 0.8% | -$11.3M -9.2% | $3.0M 3.1% | $652K 0.7% | — | — | — |
| Interest Expense | -$257K -0.1% | -$583K -0.3% | $248K 0.1% | $939K 0.6% | $400K 0.3% | $11K 0.0% | $12K 0.0% | $12K 0.0% | $12K 0.0% | $10K 0.0% |
| Interest & Investment Income | — | — | — | $129K 0.1% | $50K 0.0% | $167K 0.2% | $1.3M 1.5% | $1.5M 1.6% | $606K 0.8% | $386K 0.4% |
| Pretax Income | $14.8M 6.0% | $15.4M 7.3% | $5.6M 3.0% | $561K 0.4% | -$11.2M -9.1% | $3.3M 3.4% | $2.3M 2.6% | -$145K -0.2% | -$12.9M -16.6% | $7.0M 7.7% |
| Income Tax Expense | $2.3M 0.9% | $3.2M 1.5% | $1.0M 0.5% | $194K 0.1% | -$2.4M -2.0% | $893K 0.9% | $440K 0.5% | $163K 0.2% | -$3.0M -3.9% | $2.0M 2.2% |
| Net Income | $12.5M 5.1% | $12.2M 5.8% | $4.6M 2.5% | $367K 0.2% | -$8.8M -7.1% | $2.4M 2.4% | $1.9M 2.1% | -$308K -0.3% | -$9.8M -12.7% | $5.0M 5.5% |
| Per Share | ||||||||||
| EPS (Basic) | $1.14 | $1.12 | $0.42 | $0.03 | $-0.83 | $0.24 | $0.19 | $-0.03 | $-1.01 | $0.52 |
| EPS (Diluted) | $1.12 | $1.11 | $0.42 | $0.03 | $-0.83 | $0.24 | $0.19 | $-0.03 | $-1.01 | $0.52 |
| Weighted Avg Shares (Basic) | 11.0M | 10.9M | 10.7M | 10.6M | 10.5M | 10.0M | 9.9M | 9.8M | 9.8M | 9.7M |
| Weighted Avg Shares (Diluted) | 11.1M | 11.1M | 10.8M | 10.7M | 10.5M | 10.0M | 9.9M | 9.8M | 9.8M | 9.7M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position